Skip to main content

Stress, Cortisol and Abdominal Fat

Hundreds of millions of dollars have been spent on worthless supplements that claim to promote weight loss by reducing stress and/or cortisol. Consumers can be easily confused since advertisements cite reliable references that confirm and explain how increased stress or cortisol can increase abdominal fat deposits. For example, Cushing’s syndrome is characterized by a persistent increase in cortisol levels and abdominal obesity. But when the cause of the elevated cortisol is removed, the excess abdominal fat deposits also disappear. Chronically stressed primates that have increased cortisol also develop abdominal obesity and laboratory studies confirm a clear correlation between cortisol levels and the deposition of deep abdominal fat. A study of stressed out middle-aged Swedish men similarly showed that those with the highest cortisol levels also had the biggest beer bellies.
Stress can also contribute to “middle aged spread” because many such individuals find that chocolates, cookies candies, chips and other high fat, high carbohydrate foods relieve their anxiety. Male and female hormones normally protect against the deposition of abdominal fat but their levels start to decline after age 40. Most incoming college freshman put on extra pounds their first year, and as noted in prior Newsletters, this so-called “Freshman 15″ is also due to stress. One study showed that a sample of university women gained weight 36 times faster than aged matched controls that did not attend college. In addition to being unsightly, stress induced abdominal fat secretes large amounts of inflammatory molecules that contribute to diabetes, insulin resistance and heart attacks. How many extra pounds you are carrying around may not be as important as where that excess weight is located. People with apple shaped figures are more susceptible to these disorders as well as certain cancers compared to those with pear shapes who are just as overweight due to fatty hips and buttocks. In fact, there is good evidence that increased fat in these locations may be associated with a decreased risk for coronary disease and atherosclerosis.
Since abdominal fat also tends to increase cortisol levels, this can lead to a vicious and unhealthy cycle, especially in women. There is little doubt that increased stress and/or cortisol can cause increased abdominal fat and weight gain. However, there is absolutely no proof that any nutritional supplement reduces stress, cortisol or the deposition of abdominal fat. The problem is that consumers are confused because studies in respected medical journals such as those noted below are often cited to provide scientific support, even though they have nothing to do with these products.
http://e-pharmatimes.blogspot.in/2016/10/stress-cortisol-and-abdominal-fat.html from Health

Comments

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em

DoE - Doctrine of Equivalents

The Doctrine of Equivalents is a legal principle that is relevant to patent law, particularly in the United States, and it helps protect inventors' rights even when minor changes or substitutions have been made to a patented invention.  When an inventor applies for a patent, the claims in the patent document define the scope of protection for the invention. These claims outline the specific elements or features of the invention that are considered unique and non-obvious. If another party copies or uses the patented invention without permission, it may be considered infringement. However, in some cases, the accused infringer may make slight modifications to the invention that fall outside the literal scope of the patented claims. The Doctrine of Equivalents comes into play here. It allows the patent holder to assert that the accused infringer's modified version is still equivalent to the patented invention and, therefore, falls within the scope of the patent protection. For the

Competitive Landscape for Pharmaceutical Generic products.

Creating a competitive landscape for a pharmaceutical generic product involves analyzing the market and identifying key players, their strengths, weaknesses, and market positioning. Here's a simplified outline: **Competitive Landscape Analysis for Pharmaceutical Generic Product:** 1. **Market Overview:**    - Size of the pharmaceutical generic product market.    - Growth trends and forecasts.    - Regulatory environment and barriers to entry. 2. **Key Players:**    - List the major pharmaceutical companies producing the generic product.    - Include both global and regional players. 3. **Market Share:**    - Percentage of market share held by each major player.    - Trends in market share changes over time. 4. **Product Portfolio:**    - Types of generic products offered by each player.    - Variations in strengths, dosage forms, and delivery methods. 5. ** Competitive Advantage :**    - Identify unique selling points of each player's products.    - Cost advantages, manufacturi